Pathophysiologic basis of contrast enhancement in breast tumors

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 3, 1999, Pages 260-266

  Knopp, M V ^a,c   Weiss, E ^a   Sinn, H P ^b   Mattern, J ^a   Junkermann, H ^b   Radeleff, J ^a   Magener, A ^b   Brix, G ^a   Delorme, S ^a   Zuna, I ^a   Van Kaick, G ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c German Centre for Infection Research   (Germany)

Author keywords

Contrast enhancement; Gd chelates; MR, mammography; Pathophysiologic model

Indexed keywords

CD31 ANTIGEN; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; VASCULOTROPIN;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST FIBROADENOMA; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INTRAVENOUS DRUG ADMINISTRATION; INVASIVE CARCINOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUMOR CLASSIFICATION; TUMOR VASCULARIZATION;

ADULT; ANTIGENS, CD31; BREAST NEOPLASMS; CONTRAST MEDIA; ENDOTHELIAL GROWTH FACTORS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PERMEABILITY; REGRESSION ANALYSIS; ROC CURVE;

EID: 0032863706     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7     Document Type: Article

References (48)

1. Dvorak AM, Kohn S, Morgan ES, et al. The vesiculo-vacuolar organelle (WO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukoc Biol 1996;59:100-115.
2. Craft PS, Harris AL. Clinical prognostic significance of tumour angiogenesis. Ann Oncol 1994;5:305-311.
3. Goulding H, Abdul Rashid NF, Robertson JF, et al. Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? [see comments]. Hum Pathol 1995;26:1196-1200.
4. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma [see comments]. J Natl Cancer Inst 1992;84:1875-1887.
5. Harris AL, Zhang H, Moghaddam A, et al. Breast cancer angiogenesis - new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat 1996;38:97-108.
6. Hawkins MJ. Clinical trials of antiangiogenic agents. Curr Opin Oncol 1995;7:90-93.
7. Horak ER, Harris AL, Stuart N, Bicknell R. Angiogenesis in breast cancer. Regulation, prognostic aspects, and implications for novel treatment strategies. Ann NY Acad Sci 1993;698:71-84.
8. Marshall JL, Hawkins MJ. The clinical experience with antiangiogenic agents. Breast Cancer Res Treat 1995;36:253-261.
9. Knopp MV, Hoffmann U, Brix G, et al. Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography. Radiologe 1995;35:964-972.
10. Furman HE, Margalit R, Grobgeld D, Degani H. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. Proc Natl Acad Sci USA 1996;93:6247-6251.
11. Folkman J. Tumor angiogenesis and tissue factor [comment]. Nature Med 1996;2:167-168.
12. Kolch W, Martiny Baron G, Kieser A, Marme D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res Treat 1995;36:139-155.
13. Senger DR, Brown LF, Claffey KP, Dvorak HF. Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metast 1994;14:385-394.
14. Senger DR, van de Water L, Brown LF, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metast Rev 1993;12: 303-324.
15. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33:506-514.
16. Folkman J. Angiogenesis and breast cancer [editorial: comment]. J Clin Oncol 1994;12:441-443.
17. Gasparini G. Biological and clinical role of angiogenesis in breast cancer. Breast Cancer Res Treat 1995;36:103-107.
18. Weidner N. Angiogenesis in breast cancer. Cancer Treat Res 1996; 83:265-301.
19. Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 1997;57: 4777-4786.
20. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
21. Sinn HP, Kellerhoff NM, Kellerhoff R, Bastert G, Otto HF. Subtyping and prognostic assessment of invasive lobular breast carcinoma. Pathologe 1997;18:37-44.
22. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991;47:219-223.
23. Dvorak HF, Detmar M, Claffey KP, et al. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995;107:233-235.
24. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 1995;36:127-137.
25. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis [comment]. Cell 1994;79:185-188.
26. Senger DR. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines [comment]. Am J Pathol 1996;149:1-7.
27. Fischer U, von HD, Vosshenrich R, Vieweg I, Grabbe E. Signal characteristics of malignant and benign lesions in dynamic 2D-MRT of the breast. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1993;158:287-292.
28. Gribbestad IS, Nilsen G, Fjosne H, et al. Contrast-enhanced magnetic resonance imaging of the breast. Acta Oncol 1992;31:833-842.
29. Pearlman JD, Hibberd MG, Chuang ML, et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med 1995;1:1085-1089.
30. Brasch RC, Schwickert HC, Roberts TP, et al. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate-dimeglumine and a blood-pool macromolecular contrast medium. Acad Radiol 1996;3(suppl 2): S347-348.
31. Brasch RC, Shames DM, Cohen FM, et al. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 1994;29(suppl 2):S8-11.
32. Cohen FM, Kuwatsuru R, Shames DM, et al. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation. Invest Radiol 1994;29:970-977.
33. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR Imaging characterizations of tumor microvasculature and histologic capillary density. Acad Radiol 1996;198:813-818.
34. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 1996;183:1981-1986.
35. Qu Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 1995;43:381-389.
36. Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761.
37. Guidi AJ, Fischer L, Harris JR, Schnitt SJ. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994;86:614-619.
38. Vartanian RK, Weidner N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am J Pathol 1994;144: 1188-1194.
39. Zhang HT, Craft P, Scott PA, et al. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor Into MCF-7 human breast carcinoma cells. J Natl Cancer Inst 1995;87:213-219.
40. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993;55:371-374.
41. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
42. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-782.
43. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995;36:193-204.
44. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85:1045-1049.
45. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin North Am 1994:2:633-658.
46. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993;362:841-844.
47. Sioussat TM, Dvorak HF, Brock TA, Senger DR. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch Biochem Biophys 1993;301: 15-20.
48. Weidner N, Borgstrom P, Hillan KJ, et al. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Breast Cancer Res Treat 1991;47:211-218.